Analysis of risk factor for the development of GVHD after T cell-depleted allogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 11, 2001, Pages 620-630

  Keever Taylor, Carolyn A ^a   Bredeson, Christopher ^a   Loberiza, Fausto R ^a   Casper, James T ^a   Lawton, Colleen ^a   Rizzo, Douglas ^a   Burns, William H ^a   Margolis, David A ^a   Vesole, David H ^a   Horowitz, Mary ^a   Zhang, Mei Jie ^a   Juckett, Mark ^a   Drobyski, William R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

ABO compatibility; Bone marrow transplantation; CMV serostatus; Graft versus host disease; T cell depletion

Indexed keywords

CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; GROWTH FACTOR; HLA ANTIGEN; MEPREDNISONE; MONOCLONAL ANTIBODY; OKT 3; THYMOCYTE ANTIBODY;

ACUTE DISEASE; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; DATA ANALYSIS; DONOR; GENDER; GRAFT VERSUS HOST REACTION; HLA MATCHING; HOSPITAL; HUMAN; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; RECIPIENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE; T LYMPHOCYTE; WHOLE BODY RADIATION; ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; BLOOD GROUP INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOOD GROUP INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMAN; INFANT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034747266     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11760150     Document Type: Article

References (69)

1. Marrow transplantation from related donors other than HLA-identical siblings
2. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies
3. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
4. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: Advantage of T-cell antibodies with narrow specificities
5. T-cell depletion of HLA-identical transplants in leukemia
6. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation
7. Graft vs leukemia reactions after bone marrow transplantation
8. Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
9. B-cell differentiation following autologous, conventional or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny
10. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery
11. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
12. Transplantation of megadoses of purified haploidentical stem cells
13. Immune reconstitution following T-cell depleted bone marrow transplantation: Effect of age and post-transplantation graft rejection prophylaxis
14. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors
15. Superior survival associated with transplantation of matched unrelated versus highly HLA-disparate haploidentical family donor marrow grafts for the treatment of leukemia: Establishing a treatment algorithm for alternative donor grafts
16. Successful allogeneic marrow transplantation from closely HLA-matched unrelated donors using T-cell depletion
17. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia
18. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia
19. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation
20. Factors affecting engraftment following T cell depleted bone marrow transplantation: Role of growth factor use and CD34+ cell dose
21. Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T cell depletion
22. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults
23. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
24. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
25. The predictive value of HLA-DR oligotyping for MLC responses
26. Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients
27. Automated nucleotide sequencing reveals substantial disparity between the HLA-A2 genes of bone marrow transplant recipients and donors
28. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation
29. T10B9.1A-31 anti-T-cell monoclonal antibody: Preclinical studies and clinical treatment of solid organ allograft rejection
30. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate
31. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation
32. Future directions in selection of donors for bone marrow transplantation: Role of oligonucleotide genotyping
33. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation
34. ABO-incompatible marrow transplants
35. ABH antigens and bone marrow transplantation
36. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect
37. Reassessment of ABO-incompatibility in hematopoietic stem cell transplantation
38. ABO-incompatible bone marrow transplantation: The transfusion of incompatible plasma may exacerbate regimen-related toxicity
39. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation
40. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems
41. T10B9 (MEDI-500) mediated immunosuppression: Studies on the mechanism of action
42. A new limiting dilution culture system for the detection of T cell subsets in T cell-depleted marrow grafts
43. Influence of T cell depletion method on circulating γδ T cell reconstitution and potential role in the graft-versus-leukemia effect
44. Differential staining of human alpha beta and gamma delta T cells by the fluorescein conjugate of an anti-CD3 monoclonal antibody
45. Chronic graft-versus-host disease
46. How I treat chronic graft-versus-host disease
47. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation
48. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease
49. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy
50. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T-cell depleted and unmanipulated grafts
51. Identification of a human recent thymic emigrant phenotype
52. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
53. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
54. Immunological recovery after bone marrow transplantation: Role of age, graft-versus-host disease, prednisolone treatment and infections
55. In vitro regulation of immunoglobulin synthesis after marrow transplantation, I: T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease
56. The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation, VI: Differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting
57. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
58. Pretransplant herpesvirus serology and acute graft-versus-host disease
59. A role of herpes virus serology for the development of acute graft-versus-host disease
60. Marrow donor immunity to herpes simplex virus: Association with acute graft-versus-host disease
61. Herpes-virus immunity and acute graft-versus-host disease
62. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections
63. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
64. Detection and sequence analysis of the major immediate early and PP150 gene of latent human cytomegalovirus in spleen, liver, and kidney tissues of trauma victims
65. Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin
66. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection
67. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation
68. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
69. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis